|
1
|
Buckle DR, Erhardt PW, Ganellin CR, Kobayashi T, Perun TJ, Proudfoot J, Senn-Bilfinger J. Glossary of terms used in medicinal chemistry. Part II (IUPAC Recommendations 2013). PURE APPL CHEM 2013. [DOI: 10.1351/pac-rec-12-11-23] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The evolution that has taken place in medicinal chemistry practice as a result of
major advances in genomics and molecular biology arising from the Human Genome
Project has carried with it an extensive additional working vocabulary that has
become both integrated and essential terminology for the medicinal chemist. Some
of this augmented terminology has been adopted from the many related and
interlocked scientific disciplines with which the modern medicinal chemist must
be conversant, but many other terms have been introduced to define new concepts
and ideas as they have arisen. In this supplementary Glossary, we have attempted
to collate and define many of the additional terms that are now considered to be
essential components of the medicinal chemist’s expanded repertoire.
Collapse
Affiliation(s)
- Derek R. Buckle
- 1DRB Associates, 18 Hillfield Road, Redhill, Surrey, RH1 4AP, UK
| | - Paul W. Erhardt
- 2University of Toledo, College of Pharmacy, Center for Drug Design and Development, 2801 West Bancroft Street, Toledo, OH 43606-3390, USA
| | - C. Robin Ganellin
- 3Department of Chemistry, Christopher Ingold Laboratory, University College London, 20 Gordon Street, London, WC1H 0AJ, UK
| | - Toshi Kobayashi
- 4PhRMA, 4th Floor, Landic II Toranomon Building, 3-7-8 Minato-ku, 105-000 Japan
| | | | - John Proudfoot
- 6Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, CT 06877, USA
| | | |
Collapse
|
|
2
|
Hossain N, Ivanova S, Bergare J, Eriksson T. Spirocyclic compounds, potent CCR1 antagonists. Bioorg Med Chem Lett 2013; 23:1883-6. [DOI: 10.1016/j.bmcl.2012.12.095] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2012] [Revised: 12/25/2012] [Accepted: 12/28/2012] [Indexed: 12/18/2022]
|
|
3
|
Affiliation(s)
- James Pease
- Leukocyte Biology Section, National Heart and Lung Institute, Faculty of Medicine, MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London SW7 2AZ, U.K
| | | |
Collapse
|
|
4
|
Carter PH, Hynes J. N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338. Expert Opin Ther Pat 2010; 20:1609-18. [DOI: 10.1517/13543776.2010.518144] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
|
5
|
|